Payment of deferred offering costs Payments of Deferred Stock Issuance Costs Payments of Deferred Stock Issuance Costs Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Total future lease payments, undiscounted Lessee, Operating Lease, Liability, to be Paid Other long-term liabilities Increase (Decrease) in Other Noncurrent Liabilities Principal outstanding Term loan, gross (amount drawn) Long-Term Debt, Gross Entity Address, Postal Zip Code Entity Address, Postal Zip Code Preferred stock, outstanding (shares) Preferred Stock, Shares Outstanding Credit Facility, Tranche Three Credit Facility, Tranche Three [Member] Credit Facility, Tranche Three Loss on lease termination Gain (Loss) on Termination of Lease Maximum milestone payments Collaborative Arrangement, Maximum Milestone Payment Collaborative Arrangement, Maximum Milestone Payment Debt Instrument [Axis] Debt Instrument [Axis] Property and equipment, at cost Property, Plant and Equipment, Gross Credit facility, aggregate principal amount Line of Credit Facility, Maximum Borrowing Capacity Additional paid-in capital Additional Paid in Capital Financial Instruments [Domain] Financial Instruments [Domain] Depreciation and amortization Other Depreciation and Amortization Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Depreciation Depreciation Exercise of vested stock options (shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Interest expense for term loan Interest Expense, Debt, Excluding Amortization Interest rate Debt Instrument, Interest Rate, Stated Percentage Estimated incremental borrowing rate Operating Lease, Weighted Average Discount Rate, Percent Share-Based Payment Arrangement [Abstract] Stock issued, gross proceeds Sale of Stock, Consideration Received on Transaction, Gross Sale of Stock, Consideration Received on Transaction, Gross Beginning balance (shares) Ending balance (shares) Temporary Equity, Shares Outstanding Net (loss) income Net (loss) income Net (loss) income Net (loss) income Net Income (Loss) Attributable to Parent Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive securities excluded from computation of net income (loss) per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Proceeds from exercise of vested stock options Proceeds From Early Exercise Of Stock Options Proceeds From Early Exercise Of Stock Options Subsequent Event Type [Axis] Subsequent Event Type [Axis] Prepaid insurance Prepaid Insurance Equity Component [Domain] Equity Component [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Total assets measured at fair value Assets, Fair Value Disclosure Number of warrants Number Of Warrants Number Of Warrants Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Corporate debt securities Debt Securities, Available-for-Sale Debt Securities, Available-for-Sale Non-cash lease expense Operating Lease, Noncash Expense Operating Lease, Noncash Expense Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Number of operating segments Number of Operating Segments Lease Contractual Term [Domain] Lease Contractual Term [Domain] 2022 (remaining three months, net of landlord credits) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Statement of Cash Flows [Abstract] Entity Address, State or Province Entity Address, State or Province Level 1 Fair Value, Inputs, Level 1 [Member] R&D payroll tax receivable Payroll Tax Receivable, Current Payroll Tax Receivable, Current Other comprehensive (loss) income: Other Comprehensive Income (Loss), Net of Tax [Abstract] Unrealized gains Cash And Cash Equivalents, Accumulated Unrealized Gains, Before Tax Cash And Cash Equivalents, Accumulated Unrealized Gains, Before Tax Net cash (used in) provided by operating activities Net Cash Provided by (Used in) Operating Activities Operating lease liability, current Operating Lease, Liability, Current Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Other long-term liabilities Other Liabilities [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Clinical receivables Clinical Receivables, Current Clinical Receivables, Current Interest rate Line of Credit Facility, Interest Rate During Period Term loan, net Long-Term Debt, Excluding Current Maturities Total liabilities Liabilities Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Cash Flows From Investing Activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Stock options reserved for future grant (shares) Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Awards Available For Future Grant Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Awards Available For Future Grant Issuance of common stock upon follow-on public offering, net of issuance costs of $5,246 Stock Issued During Period, Value, New Issues Number of leases Lessee, Operating Lease, Number Of Lease Contracts Lessee, Operating Lease, Number Of Lease Contracts PDUFA Fee reimbursement Fee Reimbursement Receivable, Current Fee Reimbursement Receivable, Current Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] License agreement Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member] Property and equipment, net of accumulated depreciation Property, Plant and Equipment [Table Text Block] Preferred stock, issued (shares) Preferred Stock, Shares Issued Document Type Document Type Prepaid expenses and other current assets Schedule Of Prepaid Expenses [Table Text Block] Schedule Of Prepaid Expenses Credit Facility Agreement Debt Disclosure [Text Block] Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company 2023 Lessee, Operating Lease, Liability, to be Paid, Year One Number of vested warrants Number Of Vested Warrants Number Of Vested Warrants Other receivables Schedule Of Other Receivables [Table Text Block] Schedule Of Other Receivables End of term charge, interest rate Line of Credit Facility, Periodic Payment, Interest Rate Line of Credit Facility, Periodic Payment, Interest Rate Financial Instrument [Axis] Financial Instrument [Axis] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Revaluation of equity warrants Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings Subsequent Event Subsequent Event [Member] Document Period End Date Document Period End Date Interest receivable Interest Receivable, Current Issuance costs Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Stock options exercised prior to vesting— remaining unvested Share-based Payment Arrangement, Early-Exercised Option [Member] Share-based Payment Arrangement, Early-Exercised Option Debt Securities, Available-for-Sale [Table] Debt Securities, Available-for-Sale [Table] Follow-On Public Offering Follow-On Public Offering [Member] Follow-On Public Offering Interest income Interest Income, Other Total assets Assets Debt Disclosure [Abstract] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Accounts payable and accrued liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Additional shares to be issued upon 18-month anniversary of contract execution (shares) Additional Stock To Be Issued On Eighteen Month Agreement Anniversary, Shares, Issued for Services Additional Stock To Be Issued On Eighteen Month Agreement Anniversary, Shares, Issued for Services Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Long-term investments Long-Term Investments Total interest expense related to term loan Interest Expense, Debt Accrued payroll and benefits Employee-related Liabilities, Current Line of Credit Line of Credit [Member] Variable lease cost Variable Lease, Cost Beginning balance Ending balance Temporary Equity, Carrying Amount, Attributable to Parent Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Accretion of term loan-related costs Amortization of Debt Issuance Costs and Discounts Net (Loss) Income Per Share Earnings Per Share [Text Block] Less: undistributed income reallocated to participating securities Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted Balance Sheet Account Detail Supplemental Balance Sheet Disclosures [Text Block] Unrealized gains Equity Securities, FV-NI, Unrealized Gain Proceeds from sale of common stock under employee stock purchase plan Proceeds from Stock Plans Clinical development milestones Clinical Development Milestones [Member] Clinical Development Milestones Income tax receivable Income Taxes Receivable, Current Financial instruments measured at fair value Fair Value, by Balance Sheet Grouping [Table Text Block] Entity Registrant Name Entity Registrant Name Issuance of common stock upon follow-up public offering, net of issuance costs (shares) Stock Issued During Period, Shares, New Issues Subsequent Event Subsequent Events [Text Block] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Entity Address, City or Town Entity Address, City or Town Operating expenses: Operating Expenses [Abstract] Common stock, subject to repurchase (shares) Common Stock, Shares Subject To Repurchase Common Stock, Shares Subject To Repurchase Lease asset and liability accounts Schedule of Lease Asset and Liability Accounts [Table Text Block] Schedule of Lease Asset and Liability Accounts Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Common stock, par value (usd per share) Common Stock, Par or Stated Value Per Share Commitments and Contingencies Disclosure [Abstract] Equity securities (in shares) Equity Securities, FV-NI, Number Of Shares Equity Securities, FV-NI, Number Of Shares Fair Value Measurements Fair Value Disclosures [Text Block] Common stock issued for license agreement, share price (usd per share) Share Price Trading Symbol Trading Symbol Entity File Number Entity File Number Trade accounts payable and other Accounts Payable, Trade, Current Less: undistributed income allocated to participating securities Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Accrued interest, current Interest Payable, Current Research and development Research and Development Expense Drug Supply Agreement Milestone Drug Supply Agreement Milestone [Member] Drug Supply Agreement Milestone Laboratory equipment Other Machinery and Equipment [Member] Fair value of cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Prime Rate Prime Rate [Member] Subsequent Events [Abstract] Total revenues Revenues LianBio LianBio [Member] LianBio Restricted stock units issued and outstanding (unvested) under 2020 Equity Incentive Plan Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Restricted Stock Units Available For Future Grant Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Restricted Stock Units Available For Future Grant "Interest expense" paid in cash Interest Paid, Excluding Capitalized Interest, Operating Activities Lapse of repurchase obligation for stock option exercises, prior to vesting Stock Issued During Period, Value, Lapse Of Repurchase Rights Stock Issued During Period, Value, Lapse Of Repurchase Rights Net (loss) per share, basic (usd per share) Earnings Per Share, Basic 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three Number of tranches Warrant Agreement, Number of Tranches Warrant Agreement, Number of Tranches Counterparty Name [Domain] Counterparty Name [Domain] Total stockholders’ equity Beginning balance Ending balance Stockholders' Equity Attributable to Parent Prepaid expenses Prepaid expenses Prepaid Expense, Current Lease Contractual Term [Axis] Lease Contractual Term [Axis] Milestone payment achieved Collaborative Arrangement, Milestone Payment Collaborative Arrangement, Milestone Payment Entity Interactive Data Current Entity Interactive Data Current Stock issued (shares) Sale of Stock, Number of Shares Issued in Transaction Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Deposits Deposit Assets Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Other non-current assets Other Assets, Miscellaneous, Noncurrent Money market funds Money Market Funds [Member] Accumulated Deficit Retained Earnings [Member] Total lease expense Lease, Cost Common Stock Common Stock [Member] Stock-based compensation Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Number of reportable segments Number of Reportable Segments Components of lease cost Lease, Cost [Table Text Block] Revenue Revenue [Policy Text Block] Marketable Securities and Long-Term Investments Marketable Securities, Policy [Policy Text Block] Statement [Table] Statement [Table] Document Quarterly Report Document Quarterly Report Furniture and fixtures Furniture and Fixtures [Member] Current assets: Assets, Current [Abstract] Operating lease liability, non-current Operating Lease, Liability, Noncurrent Leasehold improvements Leasehold Improvements [Member] Accumulated deficit Retained Earnings (Accumulated Deficit) Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Equity Components [Axis] Equity Components [Axis] Comprehensive (Loss) Income Comprehensive Income, Policy [Policy Text Block] Operating Segment Segment Reporting, Policy [Policy Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Cash Flows From Operating Activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Accounts payable and other accrued liabilities Accounts payable and other accrued liabilities Accounts Payable and Other Accrued Liabilities, Current Total other income (expense), net Nonoperating Income (Expense) Variable Rate [Domain] Variable Rate [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Development and Regulatory Milestone Development And Regulatory Milestone [Member] Development And Regulatory Milestone Unrealized losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Commercial and sales milestones Commercial And Sales Milestones [Member] Commercial And Sales Milestones Document Transition Report Document Transition Report Local Phone Number Local Phone Number (Loss) income from operations before other income (expense) and income taxes Operating Income (Loss) Recently Issued or Effective Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Accretion of end of term charge Debt Instrument, Unamortized Discount (Premium), Net Effect of dilutive securities: Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract] Credit Facility, Tranche Four Credit Facility, Tranche Four [Member] Credit Facility, Tranche Four Common stock, outstanding (shares) Beginning balance (shares) Ending balance (shares) Common Stock, Shares, Outstanding Employee stock option pre-vesting exercise liability Deferred Compensation Share-Based Arrangements, Liability, Current Unrealized losses Equity Securities, FV-NI, Unrealized Loss Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Prepaid expenses Increase (Decrease) in Prepaid Expense Benefit (provision) for income taxes Income Tax Expense (Benefit) Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Common stock votes Common Stock, Number Of Votes Common Stock, Number Of Votes Preferred stock, par value (usd per share) Preferred Stock, Par or Stated Value Per Share 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Income Statement [Abstract] Additional Paid-In Capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Basic EPS Earnings Per Share, Basic [Abstract] Cost of license fees and collaboration revenue Cost of Goods and Services Sold Cash and Cash Equivalents Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block] Stock options issued and outstanding (shares) Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Options Issued And Outstanding Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Options Issued And Outstanding Weighted-average shares outstanding, diluted (shares) Diluted weighted average shares outstanding (shares) Weighted Average Number of Shares Outstanding, Diluted Debt issuance costs Debt issuance costs (legal and other administrative fees) Debt Issuance Costs, Line of Credit Arrangements, Net (Less): Accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Common stock (LianBio shares included in "long-term investments") Estimated fair value Equity Securities, FV-NI Debt Securities, Available-for-Sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Lapse of repurchase obligation for stock option exercises, prior to vesting (shares) Stock Issued During Period, Shares, Lapse Of Repurchase Rights Stock Issued During Period, Shares, Lapse Of Repurchase Rights Common stock, $0.0001 par value; 200,000,000 shares authorized; 26,671,812 shares issued and outstanding at September 30, 2022 (unaudited); 20,726,580 shares issued and 20,698,737 outstanding, which excludes 27,840 shares subject to repurchase at December 31, 2021 Common Stock, Value, Issued Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Issuance of common stock upon the vesting of restricted stock units (shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Outstanding potentially dilutive securities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Short-term lease cost (lease with 12 month term or less) Short-Term Lease, Cost Preferred stock, authorized (shares) Preferred Stock, Shares Authorized Cash and cash equivalents — beginning of period Cash and cash equivalents — end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Expensing of "operating lease right-of-use assets" upon lease termination Operating Lease, Right Of Use Asset, Lease Termination Expense Operating Lease, Right Of Use Asset, Lease Termination Expense Commitment & Contingencies Commitments and Contingencies Disclosure [Text Block] Current liabilities: Liabilities, Current [Abstract] Net (loss) income available to common shareholders Net Income (Loss) Available to Common Stockholders, Basic Accrued clinical studies Accrued Clinical Studies, Current Accrued Clinical Studies, Current Proceeds from term loan Proceeds from Issuance of Long-Term Debt Common stock, issued (shares) Common Stock, Shares, Issued Contract liability Contract with Customer, Liability, Current Additional shares to be issued upon 18-month anniversary of contract execution, value Additional Stock To Be Issued On Eighteen Month Agreement Anniversary, Value, Issued for Services Additional Stock To Be Issued On Eighteen Month Agreement Anniversary, Value, Issued for Services Summary of estimated value of cash, cash equivalents, marketable securities, and equity securities Unrealized Gain (Loss) on Investments [Table Text Block] Additions of "property and equipment, net" included within "accounts payable and other accrued liabilities" Capital Expenditures Incurred but Not yet Paid Income Statement Location [Domain] Income Statement Location [Domain] Amendment Flag Amendment Flag Cash used in investing activities Net Cash Provided by (Used in) Investing Activities Operating lease cost Operating Lease, Cost Shares issued in connection with the employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Additional shares to be issued upon 18-month anniversary of contract execution, share price (usd per share) Additional Stock To Be Issued On Eighteen Month Agreement Anniversary, Share Price, Issued for Services Additional Stock To Be Issued On Eighteen Month Agreement Anniversary, Share Price, Issued for Services Comprehensive (loss) income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Collaboration revenue Collaboration [Member] Collaboration Unrealized gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Entity Current Reporting Status Entity Current Reporting Status Credit Facility, Tranche Six Credit Facility, Tranche Six [Member] Credit Facility, Tranche Six Other assets Other assets Other Assets, Noncurrent Accrued payroll and benefits Increase (Decrease) in Employee Related Liabilities Shares issued in connection with the employee stock purchase plan (shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Counterparty Name [Axis] Counterparty Name [Axis] Summary of Interest Expense Interest Income and Interest Expense Disclosure [Table Text Block] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Cash and cash equivalents: Cash and Cash Equivalents [Abstract] Office equipment Office Equipment [Member] Stock options, unexercised—vested and unvested Share-Based Payment Arrangement, Option [Member] Other non-current assets Increase (Decrease) in Other Noncurrent Assets Exercise of vested stock options Stock Issued During Period, Value, Stock Options Exercised Term loan, net Long-Term Debt Other (expense) income, net Other Nonoperating Income (Expense) Unrealized loss on marketable securities and cash equivalents OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax Original issue price (usd per share) Sale of Stock, Price Per Share Common stock, authorized (shares) Common Stock, Shares Authorized Change in fair value of equity warrants issued by licensee Change in fair value of equity warrants issued by licensee Embedded Derivative, Gain (Loss) on Embedded Derivative, Net Income taxes payable Accrued Income Taxes, Current Restricted stock units—unvested Share-Based Payment Arrangement, Equity Instruments Other Than Options, Restricted Stock Units, Unvested [Member] Share-Based Payment Arrangement, Equity Instruments Other Than Options, Restricted Stock Units, Unvested Accumulated deficit Accumulated Other Comprehensive Income (Loss), Net of Tax Amortized cost Cash and Cash Equivalents, at Carrying Value Sales-Based Milestone Sales Milestone [Member] Sales Milestone Total current assets Assets, Current Entity Smaller Reporting Company Entity Small Business Accumulated amortization of debt issuance costs Accumulated Amortization, Debt Issuance Costs Stockholders' Equity and Equity Incentive Plans Stockholders' Equity Note Disclosure [Text Block] Revenues: Revenues [Abstract] Issuance of common stock upon in-license agreement milestone achievement Issuance of Stock and Warrants for Services or Claims Purchases of marketable securities Payments to Acquire Debt Securities, Available-for-Sale Credit Facility, Tranche Two Credit Facility, Tranche Two [Member] Credit Facility, Tranche Two Clinical milestones Clinical Milestones [Member] Clinical Milestones Summary of Significant Accounting Policies and Use of Estimates Significant Accounting Policies [Text Block] Accretion of end of term charge Amortization of Debt Discount (Premium) Credit Facility, Tranche Five Credit Facility, Tranche Five [Member] Credit Facility, Tranche Five Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Accounts receivable Increase (Decrease) in Accounts Receivable Title of 12(b) Security Title of 12(b) Security Total operating expenses Costs and Expenses Subsequent Event [Line Items] Subsequent Event [Line Items] Debt Instrument [Line Items] Debt Instrument [Line Items] Payment of term loan issuance costs Payments of Debt Issuance Costs Present value of operating lease payments Present value of operating lease payments Operating Lease, Liability Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Amortization of discount on available-for-sale debt securities Accretion (Amortization) of Discounts and Premiums, Investments LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] U.S. Treasury securities US Treasury Securities [Member] Amortized cost Debt Securities, Available-for-Sale, Amortized Cost Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted Average Number of Shares Outstanding, Diluted [Abstract] Stock issued, net proceeds Sale of Stock, Consideration Received on Transaction Long-term investments: Equity Securities, FV-NI [Abstract] Amortized cost Equity Securities, FV-NI, Cost Common stock awards reserved for future issuance under the 2020 Employee Stock Purchase Plan Common Stock, Capital Shares Reserved for Future Issuance, Employee Stock Purchase Plan Common Stock, Capital Shares Reserved for Future Issuance, Employee Stock Purchase Plan Other receivables Increase (Decrease) in Other Receivables Entity Filer Category Entity Filer Category Elanco Elanco [Member] Elanco Proceeds from issuance of common stock upon follow-on public offering, net of paid issuance costs Proceeds from Issuance of Common Stock Weighted-average shares outstanding, basic (shares) Basic weighted average shares outstanding (shares) Basic weighted average shares outstanding (shares) Weighted Average Number of Shares Outstanding, Basic Total stock-based compensation Share-Based Payment Arrangement, Expense Supplemental Disclosures Noncash Investing and Financing Activities: Noncash Investing and Financing Items [Abstract] Commitments and contingencies (Note 8) Commitments and Contingencies Security Exchange Name Security Exchange Name Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Preferred stock, $0.0001 par value; 10,000,000 authorized; no shares issued and outstanding Preferred Stock, Value, Issued Credit Facility, Tranche One Credit Facility, Tranche One [Member] Credit Facility, Tranche One Shares issued as consideration for in-license rights Stock issued for in-license agreements included within "research and development" expense Common stock issued for license agreement, value Stock Issued During Period, Value, Issued for Services Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Balances of Debt, Debt Issuance Costs, and Accumulated Accretion Schedule of Debt [Table Text Block] General and administrative General and Administrative Expense [Member] Total shares of common stock reserved (in shares) Total shares of common stock reserved (shares) Common Stock, Capital Shares Reserved for Future Issuance Changes in fair value of equity warrants Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Cover [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Upfront payment received Upfront Payment Upfront Payment Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Corporate debt securities US Government Debt Securities [Member] Total liabilities and stockholders’ equity Liabilities and Equity Unrealized gain from transactions denominated in a foreign currency Foreign Currency Transaction Gain (Loss), Unrealized Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Amortization of debt issuance costs Amortization of Debt Issuance Costs Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Common stock options (shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Diluted EPS Earnings Per Share, Diluted [Abstract] Total revenues Sales [Member] Other income (expense), net Nonoperating Income (Expense) [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Level 2 Fair Value, Inputs, Level 2 [Member] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Current Fiscal Year End Date Current Fiscal Year End Date (Less): Imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Marketable securities Marketable Securities, Current Net (loss) income available to common shareholders Net Income (Loss) Available to Common Stockholders, Diluted Net (loss) income per share, diluted (usd per share) Earnings Per Share, Diluted Sale of Stock [Domain] Sale of Stock [Domain] License fees License and Service [Member] Issuance costs related to follow-on public offering Payments of Stock Issuance Costs Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Stock details Schedule of Stock by Class [Table Text Block] Other assets Schedule of Other Assets [Table Text Block] Recognition of stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Total current liabilities Liabilities, Current 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Equity warrant rights Equity Warrant Rights Equity Warrant Rights Entity Ex Transition Period Entity Ex Transition Period Shares issued as consideration for in-license rights (shares) Common stock issued for license agreement (shares) Stock Issued During Period, Shares, Issued for Services Other income (expense): Nonoperating Income (Expense) [Abstract] Unrealized loss on equity investments Unrealized loss on equity investments Equity Securities, FV-NI, Unrealized Gain (Loss) Future contractual lease payments Lessee, Operating Lease, Liability, Maturity [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Underwriters' option Over-Allotment Option [Member] Product and Service [Axis] Product and Service [Axis] Fair Value Disclosures [Abstract] Interest expense Interest Expense Marketable securities: Debt Securities, Available-for-Sale [Abstract] Unrealized loss on marketable securities and cash equivalents Marketable Securities, Unrealized Gain (Loss) Irvine office and laboratory facility Irvine Office And Facilities Lease [Member] Irvine Office And Facilities Lease Equity [Abstract] Subsequent Event [Table] Subsequent Event [Table] Other receivables Other receivables Other Receivables, Net, Current Debt securities, available for sale and cash and cash equivalents Debt Securities, Available-For-Sale And Cash And Cash Equivalents Debt Securities, Available-For-Sale And Cash And Cash Equivalents Entity Tax Identification Number Entity Tax Identification Number Number of employment arrangements with executive officers Number Of Employment Arrangements With Executive Officers Number Of Employment Arrangements With Executive Officers Net (decrease) increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Commercial paper Commercial Paper [Member] Increments to draw on credit facility at company's election Line of Credit Facility, Draw Down Increments Line of Credit Facility, Draw Down Increments Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Research and Development Costs Research and Development Expense, Policy [Policy Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Out-License Agreement Collaborative Arrangement Disclosure [Text Block] Concentration of Credit Risk and Other Risks and Uncertainties Concentration Risk, Credit Risk, Policy [Policy Text Block] Accounts payable and other accrued liabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities City Area Code City Area Code General and administrative General and Administrative Expense ASSETS Assets: Assets [Abstract] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] End of term charge Line of Credit Facility, Periodic Payment, Interest Statement of Stockholders' Equity [Abstract] Sale of Stock [Axis] Sale of Stock [Axis] Fair value, beginning of period Fair value, end of period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Other prepaid expenses Other Prepaid Expense, Current Cash Flows From Financing Activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Net (Loss) Income per Share Earnings Per Share, Policy [Policy Text Block] Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Variable Rate [Axis] Variable Rate [Axis] Other long-term liabilities Other long-term liabilities Other Liabilities, Noncurrent Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Research and development Research and Development Expense [Member] Equity warrants (for LianBio shares included in "other assets") Equity Warrants, Fair Value Disclosure Equity Warrants, Fair Value Disclosure Net (loss) income per share, basis and diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Effective interest rate Line of Credit Facility, Interest Rate at Period End "Operating lease right-of-use asset" obtained in exchange for operating lease liability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Description of Business and Presentation of Financial Statements Business Description and Basis of Presentation [Text Block] Lotilaner licensor liability Derivative Liability, Noncurrent